Issues related to pharmaceutical manufacturing and drug pricing. Issues related to trade and tariffs.
2026 · 1st Quarter (Jan 1 - Mar 31)
DAIICHI SANKYO, INC.
Filed by MARSHALL & POPP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Feb 24, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- MARSHALL & POPP, LLC
- Client
- DAIICHI SANKYO, INC.
- Filing UUID
- 0dde4e28-b044-496a-89f0-bb48708af48c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to pharmaceutical manufacturing and drug pricing. Issues related to trade and tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.